SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-002741
Filing Date
2017-02-03
Accepted
2017-02-03 17:11:45
Documents
1
Period of Report
2017-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11767
  Complete submission text file 0000899243-17-002741.txt   13144
Mailing Address C/O ELEVEN BIOTHERAPEUTICS 215 FIRST STREET, SUITE 400 CAMBRIDGE MA 02142
Business Address
Pfeffer Cary (Reporting) CIK: 0001591092 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37998 | Film No.: 17573005

Mailing Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)